company-logo

LungLife AI, Inc., a cancer diagnostics company, develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology. It engages in developing LungLB, an AI enhanced, blood-based test to utilize machine learning to identify and count CTCs with reducing operator hands-on time and increasing test performance. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. The company is based in Thousand Oaks, California.

LungLife AI Dividend Announcement

LungLife AI does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on LungLife AI dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

LungLife AI Dividend History

LungLife AI Dividend Yield

LungLife AI current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing LungLife AI stock? Use our calculator to estimate your expected dividend yield:

LungLife AI Financial Ratios

P/E ratio-0.69
PEG ratio-4.36
P/B ratio0.39
ROE-56.38%
Payout ratio0.00%
Current ratio2.83
Quick ratio2.83
Cash Ratio2.50

LungLife AI Dividend FAQ

Does LungLife AI stock pay dividends?
LungLife AI does not currently pay dividends to its shareholders.
Has LungLife AI ever paid a dividend?
No, LungLife AI has no a history of paying dividends to its shareholders. LungLife AI is not known for its dividend payments.
Why doesn't LungLife AI pay dividends?
There are several potential reasons why LungLife AI would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will LungLife AI ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While LungLife AI has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is LungLife AI a dividend aristocrat?
LungLife AI is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is LungLife AI a dividend king?
LungLife AI is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is LungLife AI a dividend stock?
No, LungLife AI is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy LungLife AI stocks?
To buy LungLife AI you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy LungLife AI stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.